Emma is a unique yet important member of the CHD2 community because of the discovery of her ultra-rare genetic problem that is quite different from the typical case of CHD2.
Emma has a deletion of a long-noncoding RNA (lncRNA) called CHASERR that causes her to produce too much CHD2. She is the first person in the world diagnosed with this disorder. In fact, her doctors think she is the first person in the world with any genetic disease caused by a noncoding RNA.
Emma’s genetic journey started very shortly after birth and took almost 5 years to complete. At 5 months, she had her second brain MRI and it showed that the myelin in her brain, which is a type of wiring critical to delivering messages throughout the brain, was not forming like it should be. This led her family to proceed with whole exome sequencing and a variety of other metabolic tests. After consulting with experts around the world and running every clinical test that doctors could think of, her family was encouraged to pursue whole genome sequencing, which was only available on a research basis. Emma was enrolled in both the Rare Genomes Project at the Broad Institute and the Undiagnosed Diseases Network, a NIH funded research study from the NIH Common Fund.
In December of 2019, Emma was identified as having a deletion of the first three exons of her Chaserr gene and these were believed to be the cause of Emma’s problems. Thankfully and luckily, one of the researchers on Emma’s case discovered a preprint paper from the Weizmann Institute in Israel that discovered the Chaserr gene and was able to connect the dots. For most families, a genetic report is the end of the diagnostic journey – for Emma, this was the start of a second diagnostic journey. Emma’s diagnosis was so rare that scientists needed to validate the genetic results by studying her cells to validate that she was producing too much Chd2. Additionally, the scientists really wanted to find a second case and set on a global scavenger hunt.
After 18 months of hard work by a global team of scientists, Emma finally had a confirmed diagnosis. First, scientists at Northwestern University were able to clinically validate that Emma was producing too much Chd2 in induced pluripotent stem cells. Second, in the Summer of 2021, there was a second Chaserr case identified in France. Her scientific team is now working on submitting a research paper highlighting this important discovery.
Unfortunately, having too much Chd2 appears to be a more form of a Chd2 related disorder. Emma has spent over 250 days of her life in the hospital and will likely never be able to walk or talk. Nonetheless, she remains a happy, beautiful child and can melt your heart with her infectious smile. Spending time around Emma is a blessing that we cherish every single day.
The Chaserr gene is important to the Chd2 community because Chaserr may be a therapeutic target in order to upregulate Chd2 production. Her family is committed towards working with the Coalition to Cure Chd2 in order to drive treatments for all families impacted by Chd2.
It took a little longer for us to figure out that something was not right. How could we have.. known?Keep reading
His journey starts all the back in January of 2017. When Kolman was 14 months old he had his first seizure. It was one of the scariest days of my life.Keep reading
I’ll never forget the night I held her for what seemed like an eternity, while she was ..per..encing petit seizure clusters. It wasn’t the first time, but it was the worst we hadKeep reading
I remember experiencing what felt like a shiver shake in the tummy, the type of shake that.. someone would have when they feel a chill.Keep reading
Whenever he was awake he would be dosing off. I now realize that he was having seizures.. but his eyes would be rolling into his head.Keep reading
Last year, I wrote about my admission into a very exclusive, special-invitation-only parent group that will define the rest of my life.Keep reading
When the Coalition to Cure CHD2 was formed, I wanted to help but was not sure how. I would not be any good at fundraising or technical support.Keep reading
Colin was born in April 2015 at 29.5 weeks, 10.5 weeks early. He is currently 5 years old.Keep reading
Emma is a unique yet important member of the CHD2 community because of the discovery of her ultra-rare genetic problem that is quite different from the typical case of CHD2Keep reading
Having triplets plus one in one year changed my life in more ways than I ever thought possible, but it had been a long-time dream of mine and I was up for the challengeKeep reading
The journey of our daughter living with CHD2 started back in 2007 when she was 6 years old and seeing her eyes fluttering non-stop for minutes at a time, multiple times a dayKeep reading
When Savannah was approximately 6 months old, we noticed she wasn’t meeting her milestones and had a twitch/tic like tendency.Keep reading
The CHD2 Support & Research Facebook Group was one of the most meaningful groups I joined in 2019Keep reading
Aiden, and his twin brother Logan, was born in the US in 2005. They were much wanted IVF babies and were a blessing (and a handful) from day oneKeep reading
She was born at my parents’ house as I had a horror of hospitals, having quite recently given birth to an anencephalic baby that died at birth in oneKeep reading
When I was pregnant with Lucas, things were great...until his 20 week anatomy ultrasound. The tech noticed his kidneys were a little large.Keep reading
I could not have chosen a better name for my son. An angel from the day he was born, who came to teach us lessons of life and love to his parents and siblings, to give us new ways of understanding and facing lifeKeep reading
I was born on February 17, 2010 and I am super excited for my birthday! I remember when I was a baby, 15 months old, when I started having quick arm movements that I could not control.Keep reading